Idioma:

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws

Caminha, Raquel D'Aquino Garcia ; Chicrala, Gabriela Moura ; Soares Júnior, Luiz Alberto Valente ; Santos, Paulo Sérgio da Silva

Einstein (São Paulo, Brazil), 2019-07, Vol.17 (3), p.eRW4628

Brazil: Instituto Israelita de Ensino e Pesquisa Albert Einstein

Texto completo disponível

Citações Citado por

Enviar para

Título:
Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
Autor: Caminha, Raquel D'Aquino Garcia ; Chicrala, Gabriela Moura ; Soares Júnior, Luiz Alberto Valente ; Santos, Paulo Sérgio da Silva
Assuntos: Angiogenesis Inhibitors - adverse effects ; Antineoplásicos ; Assistência odontológica ; Female ; Humans ; Inibidores da angiogênese ; Jaw Diseases - chemically induced ; Male ; MEDICINE, GENERAL & INTERNAL ; Metástase neoplásica ; Osteonecrose ; Osteonecrosis - chemically induced ; Review ; Risk Factors
É parte de: Einstein (São Paulo, Brazil), 2019-07, Vol.17 (3), p.eRW4628
Descrição: To establish the profile of patients who developed antiangiogenic agent-related osteonecrosis of the jaws, and identify the treatments currently used in dental management. We searched the PubMed®/Medline® and Scopus databases using the words "osteonecrosis AND antiangiogenic therapy", with the following inclusion criteria: articles published in English, case reports, available online, and for an unlimited period. Of the 209 articles retrieved, 18 were selected, for a total of 19 case reports, since one article included two cases that met the inclusion criteria for this study. Medication-related osteonecrosis of the jaws is characterized by exposure of necrotic bone in the oral cavity that does not heal over a period of 8 weeks in patients with no previous history of radiation therapy. Antiangiogenic drugs are indicated in the treatment of certain tumors, since they stop the formation of new blood vessels, controlling tumor growth and the chance of metastasis. Dental prevention is essential in patients who will be put on antiangiogenic agents, to minimize the risk for osteonecrosis.
Editor: Brazil: Instituto Israelita de Ensino e Pesquisa Albert Einstein
Idioma: Inglês;Português

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws

Caminha, Raquel D'Aquino Garcia ; Chicrala, Gabriela Moura ; Soares Júnior, Luiz Alberto Valente ; Santos, Paulo Sérgio da Silva

Brazil: Instituto Israelita de Ensino e Pesquisa Albert Einstein

Buscando em bases de dados remotas. Favor aguardar.